Analysis of residual cancer after diagnostic breast biopsy: an argument for fine-needle aspiration cytology
- PMID: 7641015
- DOI: 10.1007/BF02307024
Analysis of residual cancer after diagnostic breast biopsy: an argument for fine-needle aspiration cytology
Abstract
Background: Diagnostic breast biopsy (DxBx) requires an effective strategy for successful treatment of breast cancer by lumpectomy or mastectomy. Clearance of margins is required to achieve local control.
Methods: We reviewed 844 malignant diagnostic biopsies. The strategy was to perform DxBx on all nonpalpable lesions and fine-needle aspiration (FNA) on all palpable lesions. When FNA was equivocal, DxBx was performed. After positive DxBx, either the biopsy cavity or FNA-positive breast mass was excised, and margins were documented with touch preparation cytology analysis (TPC) and frozen section (FS) as necessary to achieve negative margins.
Results: Outside institutions referred 430 excisional biopsies. Two hundred twenty-five (52.3%) were found to have residual cancer at surgical excision. Our institution performed 414 biopsies: 169 were performed on nonpalpable lesions in which 58% had residual tumor at resection; 245 were diagnosed by FNA of palpable lesions. Residual disease was found in 12 (5%).
Conclusions: Of patients who undergo DxBx, > 50% have residual breast cancer. It is recommended that (a) FNA be performed on all palpable masses or DxBx of nonpalpable masses; when cancer is diagnosed, proceed to surgical excision. (b) When lumpectomy is the option, margins should be reexcised and intraoperatively evaluated with TPC and FS at the time of axillary dissection.
Comment in
-
The needle biopsy should replace open excisional biopsy ... but will the surgeon's role in coordinating breast cancer treatment be diminished?Ann Surg Oncol. 1995 May;2(3):191-2. doi: 10.1007/BF02307021. Ann Surg Oncol. 1995. PMID: 7641012 No abstract available.
Similar articles
-
Lumpectomy margins, reexcision, and local recurrence of breast cancer.Am J Surg. 2000 Feb;179(2):81-5. doi: 10.1016/s0002-9610(00)00272-5. Am J Surg. 2000. PMID: 10773138
-
Re-excision operations in nonpalpable breast cancer.J Surg Oncol. 1995 Apr;58(4):225-8; discussion 229-32. doi: 10.1002/jso.2930580405. J Surg Oncol. 1995. PMID: 7723365
-
Intra-operative touch preparation cytology; does it have a role in re-excision lumpectomy?Ann Surg Oncol. 2007 Mar;14(3):1045-50. doi: 10.1245/s10434-006-9263-x. Epub 2007 Jan 6. Ann Surg Oncol. 2007. PMID: 17206481
-
Evaluation of abnormal mammography results and palpable breast abnormalities.Ann Intern Med. 2003 Aug 19;139(4):274-84. doi: 10.7326/0003-4819-139-4-200308190-00010. Ann Intern Med. 2003. PMID: 12965983 Review.
-
Close/positive margins after breast-conserving therapy: additional resection or no resection?Breast. 2013 Aug;22 Suppl 2:S115-7. doi: 10.1016/j.breast.2013.07.022. Breast. 2013. PMID: 24074771 Review.
Cited by
-
Mammographically detected breast cancer. Benefits of stereotactic core versus wire localization biopsy.Ann Surg. 1996 Jun;223(6):688-97; discussion 697-700. doi: 10.1097/00000658-199606000-00007. Ann Surg. 1996. PMID: 8645042 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Medical